Elevated liver enzymes, often discovered incidentally during routine bloodwork, present a common yet complex issue in clinical practice. The challenge lies in identifying the underlying cause and managing it effectively.
Increased liver enzymes, specifically Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST), indicate hepatocellular injury. However, these elevations can stem from a myriad of conditions, including viral hepatitis, alcohol-induced liver disease, non-alcoholic fatty liver disease (NAFLD), and drug-induced liver injury.
A comprehensive history and physical examination are crucial initial steps. They may reveal risk factors such as alcohol consumption, medication use, or signs of chronic liver disease. If the etiology remains unclear, serologic testing can help identify viral hepatitis or autoimmune liver disease. Imaging studies, especially ultrasound, can detect structural abnormalities or fatty infiltration. In some cases, liver biopsy may be necessary.
Management primarily involves addressing the underlying cause. For instance, alcohol abstinence is advised in alcohol-related liver disease, while weight loss and control of metabolic risk factors are key in NAFLD. Certain drug-induced liver injuries may require discontinuation of the offending agent. In viral hepatitis, antiviral therapy is the mainstay of treatment.
Regular follow-up with liver function tests is essential to monitor the response to treatment and detect any progression of the disease. In some cases, referral to a hepatologist may be necessary for further management.
In conclusion, the management of elevated liver enzymes necessitates a comprehensive, patient-centered approach. Understanding the various potential causes, employing a systematic diagnostic strategy, and tailoring management to the specific etiology can lead to successful patient outcomes.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation